Chand N, Nolan K, Sofia R D, Diamantis W
Wallace Laboratories, Division of Carter-Wallace, Inc., Cranbury, New Jersey.
Ann Allergy. 1990 Feb;64(2 Pt 1):151-4.
The influence of orally administered azelastine and selected H1-receptor antagonists on aeroallergen-induced acute lung anaphylactic responses in actively sensitized guinea pigs (experimental asthma model) was studied. Azelastine (1 mg/kg, PO, two hours) exerted significant inhibition of the aeroallergen-induced decline in dynamic lung compliance and an elevation in pulmonary airway resistance. Terfenadine, pyrilamine, and diphenhydramine given as oral doses of 1 mg/kg two hours before aeroallergen challenge exerted weak or no inhibition of acute lung anaphylactic responses. In conclusion, the data obtained in this study showed that azelastine administered orally is capable of exerting antiasthmatic effects in both the central and peripheral airways of guinea pigs. This effect may be attributed to its ability to inhibit the formation or secretion of pharmacologic mediators (ie, histamine, LTC4/D4, .O2-) from inflammatory cells.
研究了口服氮卓斯汀及某些选择性H1受体拮抗剂对主动致敏豚鼠(实验性哮喘模型)气源性变应原诱发的急性肺过敏反应的影响。氮卓斯汀(1毫克/千克,口服,两小时)对气源性变应原诱发的动态肺顺应性下降和肺气道阻力升高有显著抑制作用。在气源性变应原激发前两小时口服给予1毫克/千克的特非那定、吡苄明和苯海拉明,对急性肺过敏反应的抑制作用微弱或无抑制作用。总之,本研究获得的数据表明,口服氮卓斯汀能够在豚鼠的中央和外周气道发挥抗哮喘作用。这种作用可能归因于其抑制炎症细胞中药理介质(即组胺、白三烯C4/D4、超氧阴离子)形成或分泌的能力。